|
1
|
Stedman TL: Stedman's medical dictionary
for the health professions and nursing. Wolters Kluwer
Health/Lippincott Williams & Wilkins, Philadelphia, PA,
2012.
|
|
2
|
Livingston G, Sommerlad A, Orgeta V,
Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A,
Cohen-Mansfield J, et al: Dementia prevention, intervention, and
care. Lancet. 390:2673–2734. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
McIntyre RS, Cha DS, Soczynska JK,
Woldeyohannes HO, Gallaugher LA, Kudlow P, Alsuwaidan M and
Baskaran A: Cognitive deficits and functional outcomes in major
depressive disorder: Determinants, substrates, and treatment
interventions. Depress Anxiety. 30:515–527. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Tarumi T and Zhang R: Cerebral blood flow
in normal aging adults: Cardiovascular determinants, clinical
implications, and aerobic fitness. J Neurochem. 144:595–608.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou D, Meng R, Li SJ, Ya JY, Ding JY,
Shang SL, Ding YC and Ji XM: Advances in chronic cerebral
circulation insufficiency. CNS Neurosci Ther. 24:5–17.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mergenthaler P, Lindauer U, Dienel GA and
Meisel A: Sugar for the brain: The role of glucose in physiological
and pathological brain function. Trends Neurosci. 36:587–597.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Barnes DE, Beiser AS, Lee A, Langa KM,
Koyama A, Preis SR, Neuhaus J, McCammon RJ, Yaffe K, Seshadri S, et
al: Development and validation of a brief dementia screening
indicator for primary care. Alzheimers Dement. 10:656–665.e1.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nasreddine ZS, Phillips NA, Bédirian V,
Charbonneau S, Whitehead V, Collin I, Cummings JL and Chertkow H:
The montreal cognitive assessment, MoCA: A brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 53:695–699.
2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Molloy W and Clarnette R: Standardized
mini-mental state examination: A user's guide. Troy: Newgrange
Press, 1999.
|
|
10
|
Borson S, Scanlan JM, Chen P and Ganguli
M: The mini-cog as a screen for dementia: Validation in a
population-based sample. J Am Geriatr Soc. 51:1451–1454.
2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sbordone RJ: Limitations of
neuropsychological testing to predict the cognitive and behavioral
functioning of persons with brain injury in real-world settings.
NeuroRehabilitation. 16:199–201. 2001.PubMed/NCBI
|
|
12
|
Cullen B, O'Neill B, Evans JJ, Coen RF and
Lawlor BA: A review of screening tests for cognitive impairment. J
Neurol Neurosurg Psychiatry. 78:790–799. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
David AK, Taylor RB and Fields SA:
Taylor's cardiovascular diseases: A handbook. Springer, New York,
NY, 2004.
|
|
14
|
Carbonara R, Giardinelli F, Zito A,
Scicchitano P, Dentamaro I, Cortese F, Armenise A, Manca F, De Caro
MF, Nazzaro P, et al: Neuro-psychological pattern in patients
suffering from primitive dilated cardiomyopathy with impairment in
executive function. Curr Neurovasc Res. 14:39–45. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Martis A, Gusetu G, Cismaru G, Zdrenghea
D, Leucuta DC and Pop D: Improvement of cognitive function and
interleukin 1 beta serum concentrations following cardiac pacemaker
implantation in patients with symptomatic bradycardia. J Pers Med.
11(770)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Duschek S, Matthias E and Schandry R:
Essential hypotension is accompanied by deficits in attention and
working memory. Behav Med. 30:149–158. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qiu C, von Strauss E, Fastbom J, Winblad B
and Fratiglioni L: Low blood pressure and risk of dementia in the
Kungsholmen project: A 6-year follow-up study. Arch Neurol.
60:223–228. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Waldstein SR, Giggey PP, Thayer JF and
Zonderman AB: Nonlinear relations of blood pressure to cognitive
function: The baltimore longitudinal study of aging. Hypertension.
45:374–379. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hebert LE, Scherr PA, Bennett DA, Bienias
JL, Wilson RS, Morris MC and Evans DA: Blood pressure and late-life
cognitive function change: A biracial longitudinal population
study. Neurology. 62:2021–2024. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gomez CR, McLaughlin JR, Njemanze C and
Nashed A: Effect of cardiac dysfunction upon diastolic cerebral
blood flow. Angiology. 43:625–630. 1992.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ettorre E, Cicerchia M, De Benedetto G,
Fossati C, Guglielmi S, Manzon L, Servello A, Petrillo A and
Marigliano V: A possible role of atrial fibrillation as a risk
factor for dementia. Arch Gerontol Geriatr. 49 (Suppl 1):S71–S76.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Beeri MS, Ravona-Springer R, Silverman JM
and Haroutunian V: The effects of cardiovascular risk factors on
cognitive compromise. Dialogues Clin Neurosci. 11:201–212.
2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Waldstein SR and Wendell CR:
Neurocognitive function and cardiovascular disease. J Alzheimers
Dis. 20:833–842. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jerskey BA, Cohen RA, Jefferson AL, Hoth
KF, Haley AP, Gunstad JJ, Forman DE, Sweet LH and Poppas A:
Sustained attention is associated with left ventricular ejection
fraction in older adults with heart disease. J Int Neuropsychol
Soc. 15:137–141. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jefferson AL, Poppas A, Paul RH and Cohen
RA: Systemic hypoperfusion is associated with executive dysfunction
in geriatric cardiac patients. Neurobiol Aging. 28:477–483.
2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hoth KF, Poppas A, Ellison KE, Paul RH,
Sokobin A, Cho Y and Cohen RA: Link between change in cognition and
left ventricular function following cardiac resynchronization
therapy. J Cardiopulm Rehabil Prev. 30:401–408. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dixit NK, Vazquez LD, Cross NJ, Kuhl EA,
Serber ER, Kovacs A, Dede DE, Conti JB and Sears SF: Cardiac
resynchronization therapy: A pilot study examining cognitive change
in patients before and after treatment. Clin Cardiol. 33:84–88.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tisher A and Salardini A: A comprehensive
update on treatment of dementia. Semin Neurol. 39:167–178.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gay BE, Taylor KI, Hohl U, Tolnay M and
Staehelin HB: The validity of clinical diagnoses of dementia in a
group of consecutively autopsied memory clinic patients. J Nutr
Health Aging. 12:132–137. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Brunnström H and Englund E:
Clinicopathological concordance in dementia diagnostics. Am J
Geriatr Psychiatry. 17:664–670. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Roman G: Diagnosis of vascular dementia
and Alzheimer's disease. Int J Clin Pract Suppl. 120:9–13.
2001.PubMed/NCBI
|
|
32
|
Jongen PJ, Ter Horst AT and Brands AM:
Cognitive impairment in multiple sclerosis. Minerva Med. 103:73–96.
2012.PubMed/NCBI
|
|
33
|
Mavrogeni S, Pons R, Nikas I, Papadopoulos
G, Verganelakis DA, Kolovou G and Chrousos GP: Brain and heart
magnetic resonance imaging/spectroscopy in duchenne muscular
dystrophy. Eur J Clin Invest. 47:2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Vojinovic D, Adams HH, van der Lee SJ,
Ibrahim-Verbaas CA, Brouwer R, van den Hout MC, Oole E, van Rooij
J, Uitterlinden A, Hofman A, et al: The dystrophin gene and
cognitive function in the general population. Eur J Hum Genet.
23:837–843. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jaaro-Peled H and Sawa A:
Neurodevelopmental factors in schizophrenia. Psychiatr Clin North
Am. 43:263–274. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rolls ET: The cingulate cortex and limbic
systems for emotion, action, and memory. Brain Struct Funct.
224:3001–3018. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bressi S, Miele L, Bressi C, Astori S,
Gimosti E, Linciano AD, Sessini M and Invernizzi G: Deficit of
central executive component of working memory in schizophrenia. New
Trends Exp Clin Psychiatry. 12:243–252. 1996.
|
|
38
|
Gold JM, Carpenter C, Randolph C, Goldberg
TE and Weinberger DR: Auditory working memory and wisconsin card
sorting test performance in schizophrenia. Arch Gen Psychiatry.
54:159–165. 1997.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Buchsbaum MS and Hazlett EA: Positron
emission tomography studies of abnormal glucose metabolism in
schizophrenia. Schizophr Bull. 24:343–364. 1998.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Spitzer M: The psychopathology,
neuropsychology, and neurobiology of associative and working memory
in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 243:57–70.
1993.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Stone M, Gabrieli JD, Stebbins GT and
Sullivan EV: Working and strategic memory deficits in
schizophrenia. Neuropsychology. 12:278–288. 1998.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Goldberg TE, Saint-Cry JA and Weinberger
DR: Assessment of procedural learning and problem solving in
schizophrenic patients by Tower of Hanoi type tasks. J
Neuropsychiatry Clin Neurosci. 2:165–173. 1990.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Braff DL, Heaton R, Kuck J, Cullum M,
Moranville J, Grant I and Zisook S: The generalized pattern of
neuropsychological deficits in outpatients with chronic
schizophrenia with heterogeneous wisconsin card sorting test
results. Arch Gen Psychiatry. 48:891–898. 1991.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Voruganti LN, Heslegrave RJ and Awad AG:
Neurocognitive correlates of positive and negative syndromes in
schizophrenia. Can J Psychiatry. 42:1066–1071. 1997.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Young DA, Davila R and Scher H:
Unawareness of illness and neuropsychological performance in
chronic schizophrenia. Schizophr Res. 10:117–124. 1993.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Carrion C, Folkvord F, Anastasiadou D and
Aymerich M: Cognitive therapy for dementia patients: A systematic
review. Dement Geriatr Cogn Disord. 46:1–26. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Clark LD, Iversen SD and Goodwin GM:
Sustained attention deficit in bipolar disorder. Br J Psychiatry.
180:313–319. 2002.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Drubach DA: Obsessive-compulsive disorder.
Continuum (Minneap Minn). 21 (3 Behavioral Neurology and
Neuropsychiatry):783–788. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zielinski CM, Taylor MA and Juzwin KR:
Neuropsychological deficits in obsessive-compulsive disorder.
Neuropsychiatry Neuropsychol Behav Neurol. 4:110–126. 1991.
|
|
50
|
Loades ME, Chalder T, Smakowski A and
Rimes KA: Anticipation of and response to exercise in adolescents
with CFS: An experimental study. J Psychosom Res.
146(110490)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Lee CH and Giuliani F: The role of
inflammation in depression and fatigue. Front Immunol.
10(1696)2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Abbey SE and Garfenkel PE: Chronic fatigue
syndrome and depression: Cause, effect, or covariate. Rev Infect
Dis. 13 (Suppl 1):S73–S83. 1991.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Woods SP, Lovejoy DW and Ball JD:
Neuropsychological characteristics of adults with ADHD: A
comprehensive review of initial studies. Clin Neuropsychol.
16:12–34. 2002.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Magnin E and Maurs C:
Attention-deficit/hyperactivity disorder during adulthood. Rev
Neurol (Paris). 173:506–515. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Blume AW, Schmaling KB and Marlatt GA:
Memory, executive cognitive function, and readiness to change
drinking behavior. Addict Behav. 30:301–314. 2005.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Mohammadian J and Miladi-Gorji H: Age- and
sex-related changes in the severity of physical and psychological
dependence in morphine-dependent rats. Pharmacol Biochem Behav.
187(172793)2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Allen DN and Landis RKB:
Neuropsychological correlates of substance use disorders. In:
Clinical neuropsychology: A pocket handbook for assessment. Snyder
PJ and Nassbaum PD (eds). American Psychological Association,
Washington, DC, pp591-612, 1998.
|
|
58
|
Bates ME, Bowden SC and Barry D:
Neurocognitive impairment associated with alcohol use disorders:
Implications for treatment. Exp Clin Psychopharmacol. 10:193–212.
2002.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Wessels AM, Scheltens P, Barkhof F and
Heine RJ: Hyperglycaemia as a determinant of cognitive decline in
patients with type 1 diabetes. Eur J Pharmacol. 585:88–96.
2008.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Munshi MN: Cognitive dysfunction in older
adults with diabetes: What a clinician needs to know. Diabetes
Care. 40:461–467. 2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Gonder-Frederick LA, Zrebiec JF,
Bauchowitz AU, Ritterband LM, Magee JC, Cox DJ and Clarke WL:
Cognitive function is disrupted by both hypo- and hyperglycemia in
school-aged children with type 1 diabetes: A field study. Diabetes
Care. 32:1001–1006. 2009.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Strachan MW: R D Lawrence Lecture 2010.
The brain as a target organ in type 2 diabetes: Exploring the links
with cognitive impairment and dementia. Diabet Med. 28:141–147.
2011.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Maric-Bilkan C: Sex differences in micro-
and macro-vascular complications of diabetes mellitus. Clin Sci
(Lond). 131:833–846. 2017.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Diabetes Control and Complications
Trial/Epidemiology of Diabetes Interventions and Complications
Study Research Group. Jacobson AM, Musen G, Ryan CM, Silvers N,
Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, et al:
Long-term effect of diabetes and its treatment on cognitive
function. N Engl J Med. 356:1842–1852. 2007.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Jacobson AM, Ryan CM, Cleary PA, Waberski
BH, Weinger K, Musen G and Dahms W: Diabetes Control and
Complications Trial/EDIC Research Group. Biomedical risk factors
for decreased cognitive functioning in type 1 diabetes: An 18 year
follow-up of the diabetes control and complications Trial (DCCT)
cohort. Diabetologia. 54:245–255. 2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Mukherjee P, Mazumdar S, Goswami S,
Bhowmik J, Chakroborty S, Mukhopadhyay S, Jana S, Chakraborty A,
Pal S, Das SK and Mukhopadhyay J: Cognitive dysfunction in diabetic
patients with special reference to age of onset, duration and
control of diabetes. Act Nerv Super. 54:263–275. 2012.
|
|
67
|
Luchsinger JA, Ryan C and Launer LJ:
Diabetes and Cognitive Impairment. In: Diabetes in America. Cowie
CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB,
Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, et al
(eds). 3rd edition. National Institute of Diabetes and Digestive
and Kidney Diseases (US), Bethesda, MD, Chapter 24, 2018.
|
|
68
|
Cukierman-Yaffe T: Diabetes, dysglycemia
and cognitive dysfunction. Diabetes Metab Res Rev. 30:341–345.
2014.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Sato N and Morishita R: Roles of vascular
and metabolic components in cognitive dysfunction of Alzheimer
disease: Short- and long-term modification by non-genetic risk
factors. Front Aging Neurosci. 5(64)2013.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Joaquim AF and Appenzeller S:
Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun
Rev. 14:1116–1122. 2015.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Shin SY, Katz P, Wallhagen M and Julian L:
Cognitive impairment in persons with rheumatoid arthritis.
Arthritis Care Res (Hoboken). 64:1144–1150. 2012.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Gorelick PB: Role of inflammation in
cognitive impairment: Results of observational epidemiological
studies and clinical trials. Ann N Y Acad Sci. 1207:155–162.
2010.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Simos P, Ktistaki G, Dimitraki G,
Papastefanakis E, Kougkas N, Fanouriakis A, Gergianaki I, Bertsias
G, Sidiropoulos P and Karademas EC: Cognitive deficits early in the
course of rheumatoid arthritis. J Clin Exp Neuropsychol.
38:820–829. 2016.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Szekanecz Z, Kerekes G, Dér H, Sándor Z,
Szabó Z, Végvári A, Simkovics E, Soós L, Szentpétery A, Besenyei T,
et al: Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y
Acad Sci. 1108:349–358. 2007.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Coluccia D, Wolf OT, Kollias S, Roozendaal
B, Forster A and de Quervain DJ: Glucocorticoid therapy-induced
memory deficits: Acute versus chronic effects. J Neurosci.
28:3474–3478. 2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Hanly JG, Kozora E, Beyea SD and Birnbaum
J: Review: Nervous system disease in systemic lupus erythematosus:
Current status and future directions. Arthritis Rheumatol.
71:33–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Kello N, Anderson E and Diamond B:
Cognitive dysfunction in systemic lupus erythematosus: A case for
initiating trials. Arthritis Rheumatol. 71:1413–1425.
2019.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hanly JG, Urowitz MB, Su L, Bae SC, Gordon
C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, et al:
Prospective analysis of neuropsychiatric events in an international
disease inception cohort of patients with systemic lupus
erythematosus. Ann Rheum Dis. 69:529–535. 2010.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Steup-Beekman GM, Zirkzee EJ, Cohen D,
Gahrmann BM, Emmer BJ, Steens SC, Bollen EL, van Buchem MA and
Huizinga TW: Neuropsychiatric manifestations in patients with
systemic lupus erythematosus: Epidemiology and radiology pointing
to an immune-mediated cause. Ann Rheum Dis. 72 (Suppl 2):ii76–ii79.
2013.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Schwartz N, Stock AD and Putterman C:
Neuropsychiatric lupus: New mechanistic insights and future
treatment directions. Nat Rev Rheumatol. 15:137–152.
2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Bertsias GK, Ioannidis JP, Aringer M,
Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A,
Hanly JG, et al: EULAR recommendations for the management of
systemic lupus erythematosus with neuropsychiatric manifestations:
Report of a task force of the EULAR standing committee for clinical
affairs. Ann Rheum Dis. 69:2074–2082. 2010.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Brey RL, Gharavi AE and Lockshin MD:
Neurologic complications of antiphospholipid antibodies. Rheum Dis
Clin N Am. 19:833–850. 1993.PubMed/NCBI
|
|
83
|
Stock AD, Gelb S, Pasternak O, Ben-Zvi A
and Putterman C: The blood brain barrier and neuropsychiatric
lupus: New perspectives in light of advances in understanding the
neuroimmune interface. Autoimmun Rev. 16:612–619. 2017.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Barraclough M, McKie S, Parker B, Jackson
A, Pemberton P, Elliott R and Bruce IN: Altered cognitive function
in systemic lupus erythematosus and associations with inflammation
and functional and structural brain changes. Ann Rheum Dis.
78:934–940. 2019.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Ploran E, Tang C, Mackay M, Small M,
Anderson E, Storbeck J, Bascetta B, Kang S, Aranow C, Sartori C, et
al: Assessing cognitive impairment in SLE: Examining relationships
between resting glucose metabolism and anti-NMDAR antibodies with
navigational performance. Lupus Sci Med. 6(e000327)2019.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Mackay M, Vo A, Tang CC, Small M, Anderson
EW, Ploran EJ, Storbeck J, Bascetta B, Kang S, Aranow C, et al:
Metabolic and microstructural alterations in the SLE brain
correlate with cognitive impairment. JCI Insight: Jan 10, 2019
(Epub ahead of print).
|
|
87
|
Mouthon L, Alami S, Boisard AS, Chaigne B,
Hachulla E and Poiraudeau S: Patients' views and needs about
systemic sclerosis and its management: A qualitative interview
study. BMC Musculoskelet Disord. 18(230)2017.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Penn H, Howie AJ, Kingdon EJ, Bunn CC,
Stratton RJ, Black CM, Burns A and Denton CP: Scleroderma renal
crisis: Patient characteristics and long-term outcomes. QJM.
100:485–494. 2007.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Pakozdi A, Nihtyanova S, Moinzadeh P, Ong
VH, Black CM and Denton CP: Clinical and serological hallmarks of
systemic sclerosis overlap syndromes. J Rheumatol. 38:2406–2409.
2011.PubMed/NCBI View Article : Google Scholar
|
|
90
|
De Stefano P, Chizzolini C, Lalive PH and
Lascano AM: Limbic encephalitis associated with systemic sclerosis.
Mult Scler Relat Disord. 24:142–144. 2018.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Giuliodori G, Fraticelli P, Bartolini M,
Cagnetti C, Baruffaldi R, Rocchi MB, Provinciali L, Gabrielli A and
Silvestrini M: Cognitive and cerebral hemodynamic impairment in
scleroderma patients. Eur J Neurol. 16:1285–1290. 2009.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Alcocer-Castillejos N, Jiménez-González A
and Hinojosa-Azaola A: No difference in cognitive dysfunction among
patients with ANCA-associated vasculitis, rheumatoid arthritis or
chronic kidney disease. J Int Neuropsychol Soc. 25:595–602.
2019.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Athilingam P, King KB, Burgin SW,
Acker-man M, Cushman LA and Chen L: Montreal cognitive assessment
and mini-mental status examination compared as cognitive screening
tools in heart failure. Heart Lung. 40:521–529. 2011.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Koski L: Validity and applications of the
montreal cognitive assessment for the assessment of vascular
cognitive impairment. Cerebrovasc Dis. 36:6–18. 2013.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Mankovsky B, Zherdova N, van den Berg E,
Biessels GJ and de Bresser J: Cognitive functioning and structural
brain abnormalities in people with type 2 diabetes mellitus. Diabet
Med. 35:1663–1670. 2018.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Tamura Y and Araki A: Diabetes mellitus
and white matter hyperintensity. Geriatr Gerontol Int. 15 (Suppl
1):S34–S42. 2015.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Fang F, Zhan YF, Zhuo YY, Yin DZ, Li KA
and Wang YF: Brain atrophy in middle-aged subjects with type 2
diabetes mellitus, with and without microvascular complications. J
Diabetes. 10:625–632. 2018.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Moroni F, Ammirati E, Rocca MA, Filippi M,
Magnoni M and Camici PG: Cardiovascular disease and brain health:
Focus on white matter hyperintensities. Int J Cardiol Heart Vasc.
19:63–69. 2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Yin C, Li S, Zhao W and Feng J: Brain
imaging of mild cognitive impairment and Alzheimer's disease.
Neural Regen Res. 8:435–444. 2013.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Brickman AM, Muraskin J and Zimmerman ME:
Structural neuroimaging in Altheimer's disease: Do white matter
hyperintensities matter? Dialogues Clin Neurosci. 11:181–190.
2009.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Cannerfelt B, Nystedt J, Jönsen A, Lätt J,
van Westen D, Lilja A, Bengtsson A, Nilsson P, Mårtensson J and
Sundgren PC: White matter lesions and brain atrophy in systemic
lupus erythematosus patients: Correlation to cognitive dysfunction
in a cohort of systemic lupus erythematosus patients using
different definition models for neuropsychiatric systemic lupus
erythematosus. Lupus. 27:1140–1149. 2018.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Wiseman SJ, Ralston SH and Wardlaw JM:
Cerebrovascular disease in rheumatic diseases: A systematic review
and meta-analysis. Stroke. 47:943–950. 2016.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Liu X, Yang ZG, Gao Y, Xie LJ, Jiang L, Hu
BY, Diao KY, Shi K, Xu HY, Shen MT, et al: Left ventricular
subclinical myocardial dysfunction in uncomplicated type 2 diabetes
mellitus is associated with impaired myocardial perfusion: A
contrast-enhanced cardiovascular magnetic resonance study.
Cardiovasc Diabetol. 17(139)2018.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Shah RV, Abbasi SA and Kwong RY: Role of
cardiac MRI in diabetes. Curr Cardiol Rep. 16(449)2014.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Mavrogeni SI, Markousis-Mavrogenis G,
Papavasiliou A, Papadopoulos G and Kolovou G: Cardiac involvement
in duchenne muscular dystrophy and related dystrophinopathies.
Methods Mol Biol. 1687:31–42. 2018.PubMed/NCBI View Article : Google Scholar
|
|
106
|
von Knobelsdorff-Brenkenhoff F and
Schulz-Menger J: Role of cardiovascular magnetic resonance in the
guidelines of the European society of cardiology. J Cardiovasc Magn
Reson. 18(6)2016.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Mavrogeni S, Petrou E, Kolovou G,
Theodorakis G and Iliodromitis E: Prediction of ventricular
arrhythmias using cardiovascular magnetic resonance. Eur Heart J
Cardiovasc Imaging. 14:518–525. 2013.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Wehrum T, Dragonu I, Strecker C,
Schuchardt F, Hennemuth A, Drex J, Reinhard T, Böhringer D, Vach W,
Hennig J and Harloff A: Aortic atheroma as a source of
stroke-assessment of embolization risk using 3D CMR in stroke
patients and controls. J Cardiovasc Magn Reson.
19(67)2017.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Yaghi S, Liberman AL, Atalay M, Song C,
Furie KL, Kamel H and Bernstein RA: Cardiac magnetic resonance
imaging: A new tool to identify cardioaortic sources in ischaemic
stroke. J Neurol Neurosurg Psychiatry. 88:31–37. 2017.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Rosenbohm A, Schmid B, Buckert D,
Rottbauer W, Kassubek J, Ludolph AC and Bernhardt P: Cardiac
findings in amyotrophic lateral sclerosis: A magnetic resonance
imaging study. Front Neurol. 8(479)2017.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Mavrogeni SI, Kitas GD, Dimitroulas T,
Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S,
Matucci-Cerinic M, et al: Cardiovascular magnetic resonance in
rheumatology: Current status and recommendations for use. Int J
Cardiol. 217:135–148. 2016.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Mavrogeni S, Gargani L, Pepe A, Monti L,
Markousis-Mavrogenis G, De Santis M, De Marchi D,
Koutsogeorgopoulou L, Karabela G, Stavropoulos E, et al: Cardiac
magnetic resonance predicts ventricular arrhythmias in scleroderma:
The scleroderma arrhythmia clinical utility study (SAnCtUS).
Rheumatology (Oxford). 59:1938–1948. 2020.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Mavrogeni SI, Sfikakis PP,
Markousis-Mavrogenis G, Bournia VK, Poulos G, Koutsogeorgopoulou L,
Karabela G, Stavropoulos E, Katsifis G, Boki K, et al:
Cardiovascular magnetic resonance imaging pattern in patients with
autoimmune rheumatic diseases and ventricular tachycardia with
preserved ejection fraction. Int J Cardiol. 284:105–109.
2019.PubMed/NCBI View Article : Google Scholar
|
